Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Colombat

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma RegistryC D Williams, A H Goldstone, R M Pearce, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of poor prognosis Burkitt's lymphoma in adults with the Société Française d'Oncologie Pédiatrique LMB Protocol--a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC)T Philip, R Meckenstock, E Deconnick, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 25, 2015
[North-South cooperation on transfusion and hematology teaching: A Benin experience]E Lafia, L Anani, S Glitho, et al.
British Journal of Haematology|October 16, 1999
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow TransplantationD W Milligan, M C Ruiz De Elvira, H J Kolb, et al.
Bone Marrow Transplantation|April 30, 2002
Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantationJ Domenech, G Cartron, N Clement, et al.
European Journal of Haematology|December 2, 1999
Sezary syndrome in a patient with multiple myeloma: demonstration of a clonally distinct second malignancyG Cartron, P Roingeard, L Benboubker, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapyS Limat, M C Woronoff-Lemsi, N Milpied, et al.
Bone Marrow Transplantation|January 1, 1991
RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind studyN C Gorin, B Coiffier, M Hayat, et al.
Bulletin Du Cancer|January 1, 1990
[Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy]P Renou, P Colombat, F Fetissof, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma RegistryC D Williams, A H Goldstone, R M Pearce, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of poor prognosis Burkitt's lymphoma in adults with the Société Française d'Oncologie Pédiatrique LMB Protocol--a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC)T Philip, R Meckenstock, E Deconnick, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 25, 2015
[North-South cooperation on transfusion and hematology teaching: A Benin experience]E Lafia, L Anani, S Glitho, et al.
British Journal of Haematology|October 16, 1999
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow TransplantationD W Milligan, M C Ruiz De Elvira, H J Kolb, et al.
Bone Marrow Transplantation|April 30, 2002
Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantationJ Domenech, G Cartron, N Clement, et al.
European Journal of Haematology|December 2, 1999
Sezary syndrome in a patient with multiple myeloma: demonstration of a clonally distinct second malignancyG Cartron, P Roingeard, L Benboubker, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapyS Limat, M C Woronoff-Lemsi, N Milpied, et al.
Bone Marrow Transplantation|January 1, 1991
RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind studyN C Gorin, B Coiffier, M Hayat, et al.
Bulletin Du Cancer|January 1, 1990
[Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy]P Renou, P Colombat, F Fetissof, et al.
Pageof 12